Assembly Biosciences ASMB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.08M-3.0% | —— | -$9.2M+4.3% | -$10.2M+8.6% | -$8.82M+2.9% | ||
| $26K-21.2% | $32K0.0% | $32K-3.0% | $32K0.0% | $33K+3.1% | ||
| $1.12M+56.7% | $1.46M+94.5% | $1.67M+110% | $834K+0.1% | $712K-3.7% | ||
| -$523K— | $62K— | $912K— | $0+100% | -$0— | ||
| -$42K-114% | —— | $940K+76.0% | —— | $290K+9.0% | ||
| -$5.09M-11.5% | $2.02M-3.6% | —— | —— | -$4.56M-23.5% | ||
| $92K-91.4% | $2.13M— | $856K— | -$2.01M— | $1.08M— | ||
| -$7.83M+16.9% | -$7.17M— | -$9.88M-44.3% | -$9.63M-12.8% | -$9.42M-62.8% | ||
| -$22.1M+5.7% | —— | -$15.13M+0.7% | -$16.76M+2.0% | -$23.44M-27.6% | ||
| $19K— | $24K— | $42K— | $0-100% | $0-100% | ||
| $62.96M+217% | $11.55M-71.8% | $180.93M+1,130% | $17.51M-43.9% | $19.85M+434% | ||
| $57.6M+118% | $32.8M-4.1% | $22.7M-42.1% | $34.5M-5.0% | $26.43M+25.9% | ||
| -$5.38M-182% | —— | -$158.27M-746% | $16.99M+233% | $6.59M-61.9% | ||
| $0-100% | —— | —— | —— | $1.92M— | ||
| $149K-92.2% | $456K-97.3% | $171.93M— | $357K-97.1% | $1.92M— | ||
| -$27.33M-83.0% | $35.92M+263% | -$1.47M-116% | $593K+29.2% | -$14.93M-1,267% | ||
| —— | $750— | $750— | $750— | $750— | ||
| -$849K-408% | —— | $1.37M— | -$415K-188% | -$167K-114% | ||
| -$202K-38.4% | -$195K+44.8% | -$200K+42.2% | -$210K+11.8% | -$146K+68.5% | ||
| -$5.09M-11.5% | $2.02M-3.6% | —— | —— | -$4.56M-23.5% | ||
| $92K-91.4% | $2.13M— | $856K+289% | -$2.01M— | $1.08M+64.9% | ||
| $204K-6.8% | $204K-42.2% | $209K-40.5% | $219K-38.1% | $219K-39.0% | ||
| $57.6M+118% | $32.8M-4.1% | $22.7M-42.1% | $34.5M-5.0% | $26.43M+25.9% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $1.38M— | $1.38M— | $1.38M— | $1.38M— | ||
| -$7.83M+16.9% | -$7.17M— | -$9.88M-44.3% | -$9.63M-12.8% | -$9.42M-62.8% | ||
| -$22.12M+5.6% | —— | -$15.18M+0.5% | -$16.76M+2.1% | -$23.44M-27.5% | ||
| -$22.12M+5.6% | —— | -$15.18M+0.5% | -$16.76M+2.1% | -$23.44M-27.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
